BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Emcure Pharmaceuticals Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
544210
ISIN Demat
INE168P01015
Book Value (Rs)
169.4916517
NSE Symbol
EMCURE
Divident Yield %
0.21
Market Cap
(Rs In Cr.)
26,823
P/E (TTM)
40.37
EPS (TTM)
35.05
Face Value
(Rs)
10
Back
Emcure Pharmaceuticals consolidated net profit rises 49.97% in the December 2025 quarter
04-Feb-26   Hrs IST

Net profit of Emcure Pharmaceuticals rose 49.97% to Rs 230.54 crore in the quarter ended December 2025 as against Rs 153.72 crore during the previous quarter ended December 2024. Sales rose 20.42% to Rs 2363.48 crore in the quarter ended December 2025 as against Rs 1962.63 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales2363.481962.63 20
OPM %20.8518.07 -
PBDT456.62326.73 40
PBT351.94229.92 53
NP230.54153.72 50

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)